Skip to main content

Table 2 Baseline characteristics and clinical variables of patients recruited to Groups A and B by treatment group

From: FIRST-line support for Assistance in Breathing in Children (FIRST-ABC): a multicentre pilot randomised controlled trial of high-flow nasal cannula therapy versus continuous positive airway pressure in paediatric critical care

Variables

Group A

Group B

HFNC

CPAP

HFNC

CPAP

n = 16(55.2%)

n = 13(44.8%)

n = 43(51.2%)

n = 41(48.8%)

Demography

 Age (years)

n = 16

n = 13

n = 43

n = 40

  Median (IQR)

1.5 (0.6–7.0)

0.8 (0.7–1.0)

0.7 (0.2–3.0)

0.5 (0.1–1.0)

 Age group, n (%)

  <1 year

5 (31.3)

7 (53.8)

24 (55.8)

28 (70.0)

  1 to 2 years

5 (31.3)

5 (38.5)

8 (18.6)

7 (17.5)

  3 to 4 years

1 (6.3)

0 (0.0)

2 (4.7)

0 (0.0)

  5 to 9 years

2 (12.5)

0 (0.0)

5 (11.6)

3 (7.5)

  10 years and over

3 (18.8)

1 (7.7)

4 (9.3)

2 (5.0)

 Gender, n (%)

    

  Female

8 (50.0)

7 (58.3)

27 (62.8)

14 (35.0)

  Male

8 (50.0)

5 (41.7)

16 (37.2)

26 (65.0)

 Weight (kg)

n = 16

n = 13

n = 43

n = 41

  Median (IQR)

11.4 (6.1–17.1)

9.0 (7.0–12.6)

7.5 (5.0–16.3)

5.8 (3.6–10.0)

Diagnosis

 Primary reason for PICU admission, n (%)

  Apnoea

1 (6.3)

0 (0.0)

1 (2.3)

0 (0.0)

  Asthma/wheeze

3 (18.8)

0 (0.0)

1 (2.3)

1 (2.4)

  Bronchiolitis

2 (12.5)

4 (30.8)

8 (18.6)

11 (26.8)

  Cardiac

0 (0.0)

0 (0.0)

5 (11.6)

3 (7.3)

  Lung disease

7 (43.8)

7 (53.8)

13 (30.2)

9 (22.0)

  Neurological

0 (0.0)

0 (0.0)

4 (9.3)

8 (19.5)

  Neuromuscular disorder

0 (0.0)

0 (0.0)

2 (4.7)

0 (0.0)

  Sepsis

2 (12.5)

1 (7.7)

4 (9.3)

0 (0.0)

  Upper airway obstruction

1 (6.3)

1 (7.7)

4 (9.3)

4 (9.8)

  Other

0 (0.0)

0 (0.0)

1 (2.3)

5 (12.2)

 Length of invasive ventilation prior to extubation (days)

  

n = 41

n = 40

  Median (IQR)

  

3.0 (2.0–5.0)

4.0 (2.0–6.0)

 Modified COMFORT score at baseline

n = 7

n = 4

n = 15

n = 10

  Median (IQR)

17.0 (12.0–22.0)

15.0 (15.0–17.5)

17.0 (14.0–19.0)

17.0 (14.0–22.0)

Physiology at baseline

 Respiratory rate (breaths/min)

n = 14

n = 12

n = 38

n = 36

  Median (IQR)

40.5 (33.0–55.0)

42.0 (39.0–57.0)

31.5 (27.0–40.0)

33.0 (24.5–40.0)

 Heart rate (beats/min)

n = 15

n = 12

n = 38

n = 36

  Median (IQR)

148.0 (128.0–156.0)

147.5 (125.0–166.0)

138.5 (112.0–152.0)

146.5 (115.5–168.0)

 SpO2 (%)

n = 14

n = 12

n = 37

n = 35

  Median (IQR)

97.0 (94.0–98.0)

99.0 (96.5–100.0)

98.0 (95.0–99.0)

98.0 (96.0–100.0)

 PaO2 (kPa)

n = 0

n = 0

n = 8

n = 5

  Median (IQR)

–

–

8.8 (5.4,11.4)

9.5 (6.8,10.4)

 FiO2

n = 14

n = 12

n = 37

n = 33

  Median (IQR)

0.7 (0.4–0.8)

0.5 (0.4–0.7)

0.3 (0.3–0.5)

0.3 (0.3–0.4)

 pH

n = 6

n = 3

n = 14

n = 11

  Median (IQR)

7.4 (7.4–7.4)

7.3 (7.3–7.4)

7.4 (7.4–7.5)

7.3 (7.3–7.4)

 pCO2 (kPa)

n = 6

n = 3

n = 14

n = 11

  Median (IQR)

5.9 (5.4–6.6)

5.5 (4.8–7.2)

5.2 (4.6–6.8)

7.1 (6.1–7.7)

Work of breathing

 Respiratory distress, n (%)

  None

0 (0.0)

0 (0.0)

16 (53.3)

13 (44.8)

  Mild

3 (21.4)

1 (12.5)

6 (20.0)

4 (13.8)

  Moderate

8 (57.1)

4 (50.0)

3 (10.0)

9 (31.0)

  Severe

3 (21.4)

3 (37.5)

5 (16.7)

3 (10.3)

  1. CPAP continuous positive airway pressure, FiO2 fraction of inspired oxygen, HFNC high-flow nasal cannula, IQR interquartile range, PaO2 partial pressure of oxygen, pCO2 partial pressure of carbon dioxide, PICU paediatric intensive care unit, SD standard deviation, SpO2 peripheral capillary oxygen saturation